NDC 70121-1571

RELEUKO

Filgrastim

RELEUKO is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Llc. The primary component is Filgrastim.

• Product ID: 70121-1571_0b7683ae-91e8-44b0-84a6-e185b84b5664
• NDC: 70121-1571
• Product Type: Human Prescription Drug
• Proprietary Name: RELEUKO
• Generic Name: Filgrastim
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS; SUBCUTANEOUS
• Marketing Start Date: 2022-02-25
• Marketing Category: BLA /
• Application Number: BLA761082
• Labeler Name: Amneal Pharmaceuticals LLC
• Substance Name: FILGRASTIM
• Active Ingredient Strength: 480 ug/1.6mL
• Pharm Classes: Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 70121-1571-7

10 VIAL in 1 PACKAGE (70121-1571-7) > 1.6 mL in 1 VIAL

• Marketing Start Date: 2022-02-25
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "RELEUKO" or generic name "Filgrastim"

NDC	Brand Name	Generic Name
70121-1568	RELEUKO	Filgrastim
70121-1569	RELEUKO	Filgrastim
70121-1570	RELEUKO	Filgrastim
70121-1571	RELEUKO	Filgrastim
55513-209	NEUPOGEN	Filgrastim
55513-530	NEUPOGEN	Filgrastim
55513-546	NEUPOGEN	Filgrastim
55513-924	NEUPOGEN	Filgrastim